Issue Date: July 8, 2013
King Pharmaceuticals Fined For Air Pollution
King Pharmaceuticals has agreed to pay a $2.2 million fine and take steps to resolve allegations by federal prosecutors that emissions from the drug manufacturer’s Bristol, Tenn., plant violated the Clean Air Act. According to the complaint, King failed to adequately control emissions of methylene chloride and other hazardous air pollutants, violated the terms of its construction permit, and did not obtain the proper operating permit, as required under the . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society